The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
Please join AVAC and partners for two upcoming webinars, 10am ET on Thursday, October 26 and 9am ET on Friday, October 27. Thursday’s webinar is in partnership with the Treatment Action Group (TAG) and offers a chance to discuss the role of PrEP in HIV prevention trials. Friday’s webinar is with Dr. Carl Dieffenbach, and provides an additional opportunity to talk about the focus and priorities for the NIH-funded HIV clinical trial networks.
AVAC is testing a new way to bring you information and updates! Today we are introducing a podcast, Px Pulse, where advocates, researchers, policy makers and community stakeholders can hear from each other about HIV prevention research.
AVAC is pleased to announce a call for applications for participation in its inaugural PxROAR Transgender program, specifically for transgender and gender non-conforming HIV prevention advocates in Eastern and Southern Africa.
In this audio interview, Slim Abdool Karim, co-principal investigator of the landmark CAPRISA 004 study, talks about why designing trials with oral PrEP is a must—scientifically and ethically.
AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.